scholarly journals Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning

Diabetologia ◽  
1994 ◽  
Vol 37 (1) ◽  
pp. 104-110 ◽  
Author(s):  
K. C. Chiu ◽  
R. C. P. Go ◽  
M. Aoki ◽  
A. C. Riggs ◽  
Y. Tanizawa ◽  
...  
Diabetologia ◽  
1994 ◽  
Vol 37 (1) ◽  
pp. 104-110 ◽  
Author(s):  
K. C. Chiu ◽  
R. C. P. Go ◽  
M. Aoki ◽  
A. C. Riggs ◽  
Y. Tanizawa ◽  
...  

Diabetes ◽  
2012 ◽  
Vol 61 (2) ◽  
pp. 531-541 ◽  
Author(s):  
S. H. Kwak ◽  
S.-H. Kim ◽  
Y. M. Cho ◽  
M. J. Go ◽  
Y. S. Cho ◽  
...  

2006 ◽  
Vol 67 (1-2) ◽  
pp. 118-124 ◽  
Author(s):  
Izortze Santin ◽  
Guiomar Pérez de Nanclares ◽  
Begoña Calvo ◽  
Ayman Gaafar ◽  
Luis Castaño ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Yan Liu ◽  
Hui Geng ◽  
Bide Duan ◽  
Xiuzhi Yang ◽  
Airong Ma ◽  
...  

Background. Gestational diabetes mellitus (GDM) is the most prevalent metabolic disease during pregnancy, but the diagnosis is controversial and lagging partly due to the lack of useful biomarkers. CpG methylation is involved in the development of GDM. However, the specific CpG methylation sites serving as diagnostic biomarkers of GDM remain unclear. Here, we aimed to explore CpG signatures and establish the predicting model for the GDM diagnosis. Methods. DNA methylation data of GSE88929 and GSE102177 were obtained from the GEO database, followed by the epigenome-wide association study (EWAS). GO and KEGG pathway analyses were performed by using the clusterProfiler package of R. The PPI network was constructed in the STRING database and Cytoscape software. The SVM model was established, in which the β-values of selected CpG sites were the predictor variable and the occurrence of GDM was the outcome variable. Results. We identified 62 significant CpG methylation sites in the GDM samples compared with the control samples. GO and KEGG analyses based on the 62 CpG sites demonstrated that several essential cellular processes and signaling pathways were enriched in the system. A total of 12 hub genes related to the identified CpG sites were found in the PPI network. The SVM model based on the selected CpGs within the promoter region, including cg00922748, cg05216211, cg05376185, cg06617468, cg17097119, and cg22385669, was established, and the AUC values of the training set and testing set in the model were 0.8138 and 0.7576. The AUC value of the independent validation set of GSE102177 was 0.6667. Conclusion. We identified potential diagnostic CpG signatures by EWAS integrated with the SVM model. The SVM model based on the identified 6 CpG sites reliably predicted the GDM occurrence, contributing to the diagnosis of GDM. Our finding provides new insights into the cross-application of EWAS and machine learning in GDM investigation.


2011 ◽  
Vol 44 (13) ◽  
pp. S132
Author(s):  
Samaneh Enayati ◽  
Arash Hosseinnezhad ◽  
Firouzeh Birami Jamal ◽  
Zhila Maghbuli ◽  
Mahtab Khosrofar

Sign in / Sign up

Export Citation Format

Share Document